Sergei B.
Sergei B. Gashkov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20100070548 | UNIVERSAL GALOIS FIELD MULTIPLIER - An apparatus including a multiplier circuit and a multiplexing circuit. The multiplier circuit may be configured to multiply a first multiplicand and a second multiplicand based on a programmable base value and generate a plurality of intermediate values, each intermediate value representing a result of the multiplication reduced by a respective irreducible polynomial. The multiplexing circuit may be configured to generate an output in response to the plurality of intermediate values received from the multiplier circuit and the programmable base value. | 03-18-2010 |
20100293421 | LOW DEPTH PROGRAMMABLE PRIORITY ENCODERS - An apparatus having a plurality of first circuits, second circuits, third circuits and fourth circuits is disclosed. The first circuits may be configured to generate a plurality of first signals in response to (i) a priority signal and (ii) a request signal. The second circuits may be configured to generate a plurality of second signals in response to the first signals. The third circuits may be configured to generate a plurality of enable signals in response to the second signals. The fourth circuits may be configured to generate collectively an output signal in response to (i) the enable signals and (ii) the request signal. A combination of the first circuits, the second circuits, the third circuits and the fourth circuits generally establishes a programmable priority encoder. The second signals may be generated independent of the enable signals. | 11-18-2010 |
20110029980 | LOW DEPTH PROGRAMMABLE PRIORITY ENCODERS - An apparatus having a plurality of first circuits, second circuits, third circuits and fourth circuits is disclosed. The first circuits may be configured to generate a plurality of first signals in response to (i) a priority signal and (ii) a request signal. The second circuits may be configured to generate a plurality of second signals in response to the first signals. The third circuits may be configured to generate a plurality of enable signals in response to the second signals. The fourth circuits may be configured to generate collectively an output signal in response to (i) the enable signals and (ii) the request signal. A combination of the first circuits, the second circuits, the third circuits and the fourth circuits generally establishes a programmable priority encoder. The second signals may be generated independent of the enable signals. | 02-03-2011 |
Sergei B. Koralov, Millburn, NJ US
Patent application number | Description | Published |
---|---|---|
20160136122 | METHODS FOR TREATING PSORIATIC ARTHRITIS - Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) are encompassed herein. | 05-19-2016 |
Sergei B. Meleshchuk, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20080320109 | COMPLEX SOFTWARE DEPLOYMENT - Systems and methods of deploying one or more software components to a target computer infrastructure are disclosed. A descriptor file that declares a desired state of one or more target computing devices of a target computer infrastructure is parsed. A live state of the one or more target computing devices is obtained. A set of target computing devices having the live state different from the desired state is identified. A plan script that includes deployment commands configured to deploy one or more software components to each computing device is generated. The plan script can be optimized such that when executed the software components are deployed with higher efficiency, system stability, minimum downtime, etc. | 12-25-2008 |
Sergei B. Onikienko, St. Petersburg RU
Patent application number | Description | Published |
---|---|---|
20130090294 | NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS - The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70. | 04-11-2013 |
20130101573 | DEGRADATION RESISTANT HSP70 FORMULATIONS AND USES THEREOF - The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70. Furthermore, the present invention is directed to methods comprising the administration of stabilized exogenous HSP70 for use in the treatment of HSP70 related disorders or conditions, for example, for increased endurance or alleviating fatigue syndrome | 04-25-2013 |
20130156694 | HSP70 FUSION PROTEIN CONJUGATES AND USES THEREOF - The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70. | 06-20-2013 |
20140329764 | NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS - The present invention relates to novel therapies that utilize exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of exogenous HSP70. | 11-06-2014 |